CClinicalTrials.gg
CompletedNCT03540589Updated Feb 22, 2019

Distraction and Vibration for Minimizing Pain During Childhood Vaccination

An interventional study of Buzzy specific vibration device and Distraction in Pain Due to Childhood Vaccination, sponsored by Hospital Nossa Senhora da Conceicao. Completed at 1 site in Brazil. Open to participants aged 1 Year to 3 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2019-02-22.

Sponsored by Hospital Nossa Senhora da Conceicao · Not applicable, Interventional, and Prevention

Phase
Not applicable
Study type
Interventional
Enrollment
204
Allocation
Randomized
Ages
1 Year to 3 Years
Sex
All
01

Study summary

Vaccine pain control is one of the actions suggested to support the delivery of vaccines that are on a vaccine schedule, since pain and anxiety associated with vaccines are among the main reasons why children and their parents fail to do them properly. Thus, it is very important to investigate which interventions can bring greater benefit in the control of pain.This is a randomized clinical trial aiming to assess the impact of video distraction and vibration device on pain during the vaccination of children between one and three years.

02

Conditions studied

  • Pain Due to Childhood Vaccination
03

In context

Lead sponsor

Hospital Nossa Senhora da Conceicao is the lead sponsor of 21 studies on the registry; 5 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
1 Year to 3 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • Children between 1 year and 3 years, 11 months and 29 days of life.
  • Be accompanied by legal guardian.
  • Apply only one injectable vaccine at the time of the research.

Exclusion criteria

Exclusion Criteria:

  • Refuses to sign the consent form.
  • Have already been included in the study previously.
05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
204 participants (actual)

Study arms

  • Experimental
    Video distraction

    A video will be available as soon as the child is randomized to this group, thus enabling the child to become more involved with distraction. A tablet will be delivered to the parents in the reception room to be viewed by the child before entering the vaccine room. After entering the room, the parents will keep the child entertained with the videos. There will be several videos, and it may be optional for the parents to choose according to their preferences.

    Behavioral: Distraction

  • Experimental
    Vibration device

    Buzzy® specific vibration device will be placed by the professional or caregiver at the application site, 15 to 45 seconds before the procedure.

    Device: Buzzy specific vibration device

  • Experimental
    Distraction plus vibration

    Combination of the two interventions described above

    Device: Buzzy specific vibration device · Behavioral: Distraction

  • No intervention
    Usual care

    The vaccine will be carried out according to the routine of the Vaccine Center. Lidocaine plus prilocaine, non-nutritive sucking or breastfeeding may be used.

Interventions

  • DeviceBuzzy specific vibration device

    It is a device that produces vibration

  • BehavioralDistraction

    The distraction will be obtained through tablet with videos

06

What researchers measure

Primary outcomes

  1. Duration of crying in seconds

    The duration of crying will be used as surrogate endpoint to assess pain

    Time frame: Through study completion, an average 6 months

Secondary outcomes

  1. The satisfaction of parents

    The satisfaction of parents will be evaluated through a questionnaire

    Time frame: Through study completion, an average 6 months

07

Study locations

1 site
  • Hospital Moinhos de Vento
    Porto Alegre, Rio Grande Do Sul, Brazil
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Feb 22, 2019, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT03540589
Lead sponsor
Hospital Nossa Senhora da Conceicao
Responsible party
Marcio Manozzo Boniatti (Professor, Hospital Nossa Senhora da Conceicao) — Principal investigator
First posted
May 30, 2018
Start date
May 21, 2018
Primary completion
Oct 30, 2018
Completion
Oct 30, 2018
Last update
Feb 22, 2019

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Feb 2019. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion